JCR pharmaceuticals logo. Click here to go to the home page
  • Visit JCR Japan
  • Visit JCR Japan
  • Home
  • Who we are
  • Innovation
  • Pipeline
  • Patients & families
  • Our commitment
  • Partnerships
  • Investors & media
  • Our products
  • Contact us

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Reports

FY2025 first quarter results conference call script


by Moises Zanetti

Corporate governance report


by Moises Zanetti

Consolidated financial results for the three months ended June 30, 2025 (FY2025)


by Moises Zanetti

FY2025 first quarter results conference call


by Moises Zanetti

Notice regarding the completion of payment for the disposition of treasury stock as restricted stock compensation


by Moises Zanetti

Notice of resolutions passed at the 50th ordinary general meeting of shareholders


by Moises Zanetti

Matters concerning controlling shareholders (affiliated companies)


by Moises Zanetti

Notice regarding the disposition of treasury stock as restricted stock compensation


by Moises Zanetti

Other matters subject to measures for electronic provision when convening the 50th ordinary general meeting of shareholders


by Moises Zanetti

Notice of convocation of the 50th ordinary general meeting of shareholders


by Moises Zanetti

  • 1
  • 2
  • 3
Contact us
JCR pharmaceuticals logo. Click here to go to the home page

  • Sitemap
  • Compliance
  • Privacy policy
  • Global policy
  • Cookie policy
  • Cookie settings

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Privacy Preference Center

Privacy Preferences